September 20, 2024 Exploring Key Strategies for Scaling Up MCM Manufacturing at the i-MCM-Net Partners Meeting CEO DCVMN Advocacy developingcountries
August 15, 2024 Panacea Biotec and ICMR initiate Phase III Clinical Trial of DengiAll clinicaltrials Dengue
August 1, 2024 DCVMN at the Global Pandemic Preparedness Summit 2024 CEO DCVMN Advocacy WeConnectToProtect
July 2, 2024 DCVMN CEO in the “2nd Edition of The Global Event on Harnessing Private Sector Engagement for Sustainable Vaccine and Pharmaceutical Manufacturing in Africa” Africa DCVMN Advocacy Vaccines & immunization WeConnectToProtect
June 28, 2024 Regulatory Working Group Workshop on Next-Generation Sequencing (NGS) technology DCVMN achievements DCVMN Working Groups Vaccines & immunization
June 25, 2024 DCVMN at the Global Forum for Vaccine Sovereignty and Innovation CEO DCVMN Advocacy Vaccines & immunization
June 2, 2024 DCVMN at the “Advancing Biomanufacturing Workforce Training for Global Health Equity” Advocacy Event CEO DCVMN Advocacy Workforce Training
June 2, 2024 DCVMN CEO Attended a Private Session at the Permanent Mission of France to the UN in Geneva CEO DCVMN Advocacy Sustainable Regional Manufacturing WeConnectToProtect
May 29, 2024 DCVMN Joint Statement at WHA77 DCVMN Advocacy Pandemic Preparedness Statement Vaccines & immunization
